Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Oct 2021. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2039761000001116 | Relugolix + Estradiol + Norethisterone acetate | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 2039771000001114 | Relugolix + Estradiol + Norethisterone acetate (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Relugolix + Estradiol + Norethisterone acetate | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier | ||
| Relugolix + Estradiol + Norethisterone acetate | Is a | Product containing gonadotropin releasing hormone receptor antagonist | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Generic Ryeqo 40mg/1mg/0.5mg tablets | Is a | True | Relugolix + Estradiol + Norethisterone acetate | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR